The complex challenges of supporting in-market rare disease therapies and launching new ones require specialized expertise and dedicated resources.

Anovo was thoughtfully built for rare and orphan therapeutics. They are our singular, dedicated focus. 

Our specialization has enabled us to create a comprehensive and integrated approach, entirely in-house, that addresses every challenge and orchestrates every moving part for clinicians and patients.

We magnify the efficiencies of our comprehensive support by working with manufacturers as their exclusive partner for the medications we support.

This dedicated, exclusive model is unique in the industry and uniquely successful. It drives Anovo's best-in-class patient experience, reimbursement, and cost-effectiveness.

Our quality and consistency earn industry-leading satisfaction metrics for manufacturers, patients, and their caregivers.

Anovo has thought of everything and leaves nothing to chance. In every aspect of your program, our dedicated, exclusive, hands-on approach delivers benefits that drive your success.

Your patient experiences and market messaging are simplified and standardized.

Your payer contracting and coverage for new products happen faster.

Your supply chain minimizes product movements and associated risks.

Your data and market feedback come from a single, consistent source.

Your ability to make informed decisions increases while your timeline to implement changes, gets shorter.

Your program's customization and flexibility are on the table every day, and your control increases, while your financial structure, billing, and accounting get simpler. 

By being dedicated to one thing, and doing it better than anyone else, Anovo delivers on the promise of being a true extension of your team and your business.

We manage and deliver everything you and your patients need in a way that is unique and uniquely successful.